Proteomics is the large-scale study of proteins, particularly their structures and functions. Proteins are vital parts of living organisms, as they are the main components of the physiological metabolic pathways of cells. The transformation of the biopharmaceutical industry’s focus from genomics to system biology has enormously increased the importance of proteomics.
The need to develop more reliable and cost-effective drugs and increasing emphasis on personalized medicines are necessitating in-depth research on proteomics. The growing awareness of protein study and research has opened up the market for various proteomic-related technologies, equipment, and services.
This research report divides proteomics market into four major segments, namely, instrumentation technology, reagents, applications and services. Increasing innovations and developments in the field of proteomics instrumentation, availability of funds from various organizations, and increasing research and development expenditure is driving the growth of the instrumentation and reagents market.
The geographies covered in this study are North America (U.S., Canada, Mexico), Europe (U.K., France, Italy, The Netherlands, Spain), Asia-Pacific (China, Japan, Australia, New Zealand), and Rest of the World (Africa, Latin America, Middle East). North America is the largest market for proteomics, with the U.S. taking the lion’s share, followed by Europe, and Asia
This report provides comprehensive analysis of more than 25 top players of Proteomics industry with respect to their company overview, financials, portfolio, recent developments and strategies.
Source: Expert Interviews, Government Authorities, Related associations/Institutes, Related Research Publication, Government Publication, Company Press Release, Company Annual Reports, Company Website, Company Publication, SEC Filings, Meticulous Analysis.